Immunomodulation of nanoparticles in nanomedicine applications

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Jiao, Qing ^a   Li, Liwen ^a   Mu, Qingxin ^b,c   Zhang, Qiu ^a  

^a SHANDONG UNIVERSITY   (China)

^b USA   (United States)

^c University of Washington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOTUBE; CERIUM OXIDE NANOPARTICLE; DENDRIMER; FULLERENE; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; NANOCARRIER; NANOPARTICLE; PLASMA PROTEIN; POLYMER; QUANTUM DOT; SILICA NANOPARTICLE; SILVER NANOPARTICLE; UNCLASSIFIED DRUG;

CHEMICAL COMPOSITION; DRUG DELIVERY SYSTEM; DRUG EXPOSURE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; NANOCHEMISTRY; NANOMEDICINE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PLASMA PROTEIN BINDING; REVIEW; SURFACE PROPERTY; CHEMISTRY; DRUG EFFECTS; IMMUNIZATION;

HUMANS; IMMUNIZATION; IMMUNOMODULATION; IMMUNOSUPPRESSION; NANOMEDICINE; NANOPARTICLES;

EID: 84902213633     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/426028     Document Type: Review

References (154)

1. Vanić Ž., Škalko-Basnet N., Nanopharmaceuticals for improved topical vaginal therapy: can they deliver? The European Journal of Pharmaceutical Sciences 2013 50 1 29 41 10.1016/j.ejps.2013.04.035
2. Lim C.-K., Heo J., Shin S., Nanophotosensitizers toward advanced photodynamic therapy of cancer. Cancer Letters 2013 334 2 176 187 10.1016/j.canlet.2012.09.012
3. Corot C., Petry K. G., Trivedi R., Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Investigative Radiology 2004 39 10 619 625 2-s2.0-4644320733 10.1097/01.rli.0000135980.08491.33 (Pubitemid 39287601)
4. Kim C. K., Ghosh P., Pagliuca C., Zhu Z., Menichetti S., Rotello V. M., Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. Journal of the American Chemical Society 2009 131 4 1360 1361 2-s2.0-63149148294 10.1021/ja808137c
5. Wang X., Li J., Wang Y., A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model. ACS Nano 2011 5 8 6184 6194 2-s2.0-80052061132 10.1021/nn200739q
6. Li R., Wu R., Zhao L., Wu M., Yang L., Zou H., P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells. ACS Nano 2010 4 3 1399 1408 2-s2.0-77950160186 10.1021/nn9011225
7. Nam J. M., Thaxton C. S., Mirkin C. A., Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 2003 301 5641 1884 1886 2-s2.0-0141868926 10.1126/science.1088755 (Pubitemid 37221389)
8. Chang H.-H., Moura J. M. F., Wu Y. L., Ho C., Automatic detection of regional heart rejection in USPIO-enhanced MRI. IEEE Transactions on Medical Imaging 2008 27 8 1095 1106 2-s2.0-48549091396 10.1109/TMI.2008.918329
9. Riehemann K., Schneider S. W., Luger T. A., Godin B., Ferrari M., Fuchs H., Nanomedicine: challenge and perspectives. Angewandte Chemie: International Edition 2009 48 5 872 897 2-s2.0-58349119348 10.1002/anie.200802585
10. Janeway C., Travers P., Hunt S., Immunobiology: The Immune System in Health and Disease 1996 7 Current Biology
11. Hussain S., Vanoirbeek J. A. J., Hoet P. H. M., Interactions of nanomaterials with the immune system. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2012 4 2 169 183 2-s2.0-84857121722 10.1002/wnan.166
12. Descotes J., Choquet-Kastylevsky G., van Ganse E., Vial T., Responses of the immune system to injury. Toxicologic Pathology 2000 28 3 479 481 2-s2.0-0034049979 (Pubitemid 30394826)
13. Dobrovolskaia M. A., McNeil S. E., Immunological properties of engineered nanomaterials. Nature Nanotechnology 2007 2 8 469 478 2-s2.0-34547690726 10.1038/nnano.2007.223 (Pubitemid 47220069)
14. Zogovic N. S., Nikolic N. S., Vranjes-Djuric S. D., Opposite effects of nanocrystalline fullerene (C60) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C60. Biomaterials 2009 30 36 6940 6946 2-s2.0-70350534260 10.1016/j.biomaterials. 2009.09.007
15. Parween S., Gupta P. K., Chauhan V. S., Induction of humoral immune response against PfMSP-119 and PvMSP-119 using gold nanoparticles along with alum. Vaccine 2011 29 13 2451 2460 2-s2.0-79952360460 10.1016/j.vaccine.2011.01. 014
16. Ryan J. J., Bateman H. R., Stover A., Fullerene nanomaterials inhibit the allergic response. Journal of Immunology 2007 179 1 665 672 2-s2.0-34250816184 (Pubitemid 46986585)
17. Mitchell L. A., Gao J., Wal R. V., Gigliotti A., Burchiel S. W., McDonald J. D., Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicological Sciences 2007 100 1 203 214 2-s2.0-35448953505 10.1093/toxsci/kfm196 (Pubitemid 47617817)
18. Mitchell L. A., Lauer F. T., Burchiel S. W., McDonald J. D., Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nature Nanotechnology 2009 4 7 451 456 2-s2.0-67651227154 10.1038/nnano.2009.151
19. Tkach A. V., Shurin G. V., Shurin M. R., Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. ACS Nano 2011 5 7 5755 5762 2-s2.0-79961094494 10.1021/nn2014479
20. Wang X., Katwa P., Podila R., Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6 mice. Particle and Fibre Toxicology 2011 8 1, article 24 2-s2.0-80051788917 10.1186/1743-8977-8-24
21. Katwa P., Wang X., Urankar R. N., A carbon nanotube toxicity paradigm driven by mast cells and the IL-33/ST2 axis. Small 2012 8 18 2904 2912 10.1002/smll.201200873
22. Kosaka N., Mitsunaga M., Choyke P. L., Kobayashi H., In vivo real-time lymphatic draining using quantum-dot optical imaging in mice. Contrast Media & Molecular Imaging 2013 8 1 96 100 10.1002/cmmi.1487
23. Wang X., Podila R., Shannahan J., Rao A., Brown J., Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33/ST2 axis. International Journal of Nanomedicine 2013 8 1733 1748 10.2147/IJN.S44211
24. Meng J., Yang M., Jia F., Xu Z., Kong H., Xu H., Immune responses of BALB/c mice to subcutaneously injected multi-walled carbon nanotubes. Nanotoxicology 2011 5 4 583 591 2-s2.0-80655144973 10.3109/17435390.2010.523483
25. Ryman-Rasmussen J. P., Tewksbury E. W., Moss O. R., Cesta M. F., Wong B. A., Bonner J. C., Inhaled multiwalled carbon nanotubes potentiate airway fibrosis in murine allergic asthma. The American Journal of Respiratory Cell and Molecular Biology 2009 40 3 349 358 2-s2.0-61549121705 10.1165/rcmb.2008-0276OC
26. Inoue K.-I., Koike E., Yanagisawa R., Hirano S., Nishikawa M., Takano H., Effects of multi-walled carbon nanotubes on a murine allergic airway inflammation model. Toxicology and Applied Pharmacology 2009 237 3 306 316 2-s2.0-65749116404 10.1016/j.taap.2009.04.003
27. Yudoh K., Karasawa R., Masuko K., Kato T., Water-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis. International Journal of Nanomedicine 2009 4 217 225 2-s2.0-75649112637
28. Park E.-J., Kim H., Kim Y., Yi J., Choi K., Park K., Carbon fullerenes (C60s) can induce inflammatory responses in the lung of mice. Toxicology and Applied Pharmacology 2010 244 2 226 233 2-s2.0-77950072894 10.1016/j.taap.2009. 12.036
29. Chen B. X., Wilson S. R., Das M., Coughlin D. J., Erlanger B. F., Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics. Proceedings of the National Academy of Sciences of the United States of America 1998 95 18 10809 10813 2-s2.0-0032167918 10.1073/pnas.95.18. 10809 (Pubitemid 28413150)
30. Tsao N., Luh T., Chou C., Wu J., Lin Y., Lei H., Inhibition of group A streptococcus infection by carboxyfullerene. Antimicrobial Agents and Chemotherapy 2001 45 6 1788 1793 2-s2.0-0035018311 10.1128/AAC.45.6.1788-1793. 2001 (Pubitemid 32466349)
31. Jovanović B., Anastasova L., Rowe E. W., Palić D., Hydroxylated fullerenes inhibit neutrophil function in fathead minnow (Pimephales promelas Rafinesque, 1820). Aquatic Toxicology 2011 101 2 474 482 2-s2.0-78650880585 10.1016/j.aquatox.2010.11.002
32. Simpson C. A., Huffman B. J., Gerdon A. E., Cliffel D. E., Unexpected toxicity of monolayer protected gold clusters eliminated by PEG-thiol place exchange reactions. Chemical Research in Toxicology 2010 23 10 1608 1616 2-s2.0-77958088616 10.1021/tx100209t
33. Simpson C. A., Agrawal A. C., Balinski A., Harkness K. M., Cliffel D. E., Short-chain PEG mixed monolayer protected gold clusters increase clearance and red blood cell counts. ACS Nano 2011 5 5 3577 3584 2-s2.0-80051493004 10.1021/nn103148x
34. Cho W.-S., Cho M., Jeong J., Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicology and Applied Pharmacology 2009 236 1 16 24 2-s2.0-62249098384 10.1016/j.taap.2008.12.023
35. Truong L., Tilton S. C., Zaikove T., Surface functionalities of gold nanoparticles impact embryonic gene expression responses. Nanotoxicology 2013 7 2 192 201 10.3109/17435390.2011.648225
36. Hussain S., Vanoirbeek J. A. J., Luyts K., Lung exposure to nanoparticles modulates an asthmatic response in a mouse model. European Respiratory Journal 2011 37 2 299 309 2-s2.0-79953653520 10.1183/09031936.00168509
37. Chen H., Dorrigan A., Saad S., Hare D. J., Cortie M. B., Valenzuela S. M., In vivo study of spherical gold nanoparticles: inflammatory effects and distribution in mice. PLoS ONE 2013 8 2 e58208 10.1371/journal.pone.0058208
38. Sumbayev V. V., Yasinska I. M., Garcia C. P., Gold nanoparticles downregulate interleukin-1-induced pro-inflammatory responses. Small 2013 9 3 472 477 10.1002/smll.201201528
39. Lee H.-Y., Choi Y., Jung E., Genomics-based screening of differentially expressed genes in the brains of mice exposed to silver nanoparticles via inhalation. Journal of Nanoparticle Research 2010 12 5 1567 1578 2-s2.0-77955088340 10.1007/s11051-009-9666-2
40. Liu H., Yang D., Yang H., Comparative study of respiratory tract immune toxicity induced by three sterilisation nanoparticles: silver, zinc oxide and titanium dioxide. Journal of Hazardous Materials 2013 248-249 478 486 10.1016/j.jhazmat.2013.01.046
41. Fifis T., Gamvrellis A., Crimeen-Irwin B., Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. Journal of Immunology 2004 173 5 3148 3154 2-s2.0-4344697146 (Pubitemid 39142021)
42. Zhu M., Tian X., Song X., Nanoparticle-induced exosomes target antigen-presenting cells to initiate Th1-type immune activation. Small 2012 8 18 2841 2848 10.1002/smll.201200381
43. Zhu M., Li Y., Shi J., Feng W., Nie G., Zhao Y., Exosomes as extrapulmonary signaling conveyors for nanoparticle-induced systemic immune activation. Small 2012 8 3 404 412 10.1002/smll.201101708
44. Shen C. C., Liang H. H., Wang C. C., Liao M. H., Jan T. R., Iron oxide nanoparticles suppressed T helper 1 cell-mediated immunity in a murine model of delayed-type hypersensitivity. International Journal of Nanomedicine 2012 7 2729 2737 10.2147/IJN.S31054
45. Ban M., Langonné I., Huguet N., Guichard Y., Goutet M., Iron oxide particles modulate the ovalbumin-induced Th2 immune response in mice. Toxicology Letters 2013 216 1 31 39 10.1016/j.toxlet.2012.11.003
46. Wingard C. J., Walters D. M., Cathey B. L., Mast cells contribute to altered vascular reactivity and ischemia-reperfusion injury following cerium oxide nanoparticle instillation. Nanotoxicology 2011 5 4 531 545 2-s2.0-80655125258 10.3109/17435390.2010.530004
47. Ma J. Y., Zhao H., Mercer R. R., Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicology 2011 5 3 312 325 2-s2.0-80052047847 10.3109/17435390.2010.519835
48. Cho W.-S., Duffn R., Poland C. A., Metal oxide nanoparticles induce unique infammatory footprints in the lung: important implications for nanoparticle testing. Environmental Health Perspectives 2010 118 12 1699 1706 2-s2.0-78650269106 10.1289/ehp.1002201
49. Srinivas A., Rao P. J., Selvam G., Murthy P. B., Reddy P. N., Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicology Letters 2011 205 2 105 115 2-s2.0-79960698500 10.1016/j.toxlet.2011.05.1027
50. Gagné F., Auclair J., Turcotte P., Ecotoxicity of CdTe quantum dots to freshwater mussels: impacts on immune system, oxidative stress and genotoxicity. Aquatic Toxicology 2008 86 3 333 340 2-s2.0-39149145433 10.1016/j.aquatox.2007.11.013
51. Gagné F., Fortier M., Yu L., Immunocompetence and alterations in hepatic gene expression in rainbow trout exposed to CdS/CdTe quantum dots. Journal of Environmental Monitoring 2010 12 8 1556 1565 2-s2.0-77955464233 10.1039/c0em00031k
52. Morishige T., Yoshioka Y., Inakura H., Suppression of nanosilica particle-induced inflammation by surface modification of the particles. Archives of Toxicology 2012 86 8 1297 1307 10.1007/s00204-012-0823-5
53. Chen Q., Xue Y., Sun J., Kupffer cell-mediated hepatic injury induced by silica nanoparticles in vitro and in vivo. International Journal of Nanomedicine 2013 8 1129 1140 10.2147/IJN.S42242
54. Hardy C. L., LeMasurier J. S., Belz G. T., Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation. Journal of Immunology 2012 188 3 1431 1441 2-s2.0-84856562857 10.4049/jimmunol.1100156
55. Getts D. R., Martin A. J., McCarthy D. P., Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nature Biotechnology 2012 30 12 1217 1224 10.1038/nbt.2434
56. Daftarian P. M., Stone G. W., Kovalski L., A targeted and adjuvanted nanocarrier lowers the effective dose of liposomal amphotericin B and enhances adaptive immunity in murine cutaneous leishmaniasis. Journal of Infectious Diseases 2013 208 11 1914 1922 10.1093/infdis/jit378
57. Saljoughian N., Zahedifard F., Doroud D., Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice. Parasite Immunology 2013 35 12 397 408 10.1111/pim.12042
58. Weilhammer D. R., Blanchette C. D., Fischer N. O., The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge. Biomaterials 2013 34 38 10305 10318 10.1016/j.biomaterials.2013.09.038
59. Chanan-Khan A., Szebeni J., Savay S., Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions. Annals of Oncology 2003 14 9 1430 1437 2-s2.0-0141725521 10.1093/annonc/mdg374 (Pubitemid 37185291)
60. Mahajan S., Koul V., Choudhary V., Preparation and in vitro evaluation of folate-receptor-targeted SPION-polymer micelle hybrids for MRI contrast enhancement in cancer imaging. Nanotechnology 2013 24 1 015603 10.1088/0957-4484/24/1/015603
61. Eldar-Boock A., Polyak D., Scomparin A., Satchi-Fainaro R., Nano-sized polymers and liposomes designed to deliver combination therapy for cancer. Current Opinion in Biotechnology 2013 24 4 682 689 10.1016/j.copbio.2013.04.014
62. Jaiswal J. K., Simon S. M., Belling the cat-tagging live cells with quantum dots. Clinical Chemistry 2013 59 6 995 996 10.1373/clinchem.2012.199166
63. Liu C. H., Huang S., Cui J., MR contrast probes that trace gene transcripts for cerebral ischemia in live animals. The FASEB Journal 2007 21 11 3004 3015 2-s2.0-34548507223 10.1096/fj.07-8203com (Pubitemid 47372766)
64. Kostarelos K., Bianco A., Prato M., Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nature Nanotechnology 2009 4 10 627 633 2-s2.0-70350662339 10.1038/nnano.2009.241
65. Podesta J. E., Al-Jamal K. T., Herrero M. A., Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model. Small 2009 5 10 1176 1185 2-s2.0-67649890883 10.1002/smll.200801572
66. Zhang H., Grüner G., Zhao Y., Recent advancements of graphene in biomedicine. Journal of Materials Chemistry B 2013 1 20 2542 10.1039/c3tb20405g
67. Akhavan O., Ghaderi E., Escherichia coli bacteria reduce graphene oxide to bactericidal graphene in a self-limiting manner. Carbon 2012 50 5 1853 1860 2-s2.0-84856701319 10.1016/j.carbon.2011.12.035
68. Loo C., Lin A., Hirsch L., Nanoshell-enabled photonics-based imaging and therapy of cancer. Technology in Cancer Research & Treatment 2004 3 1 33 40 2-s2.0-1342301607 (Pubitemid 38250466)
69. Cheng Y., Samia A. C., Meyers J. D., Panagopoulos I., Fei B., Burda C., Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. Journal of the American Chemical Society 2008 130 32 10643 10647 2-s2.0-49449105371 10.1021/ja801631c
70. Tran Q. H., Nguyen V. Q., Le A.-T., Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives. Advances in Natural Sciences: Nanoscience and Nanotechnology 2013 4 3 033001 10.1088/2043-6262/4/3/ 033001
71. Kraft J. C., Freeling J. P., Wang Z., Ho R. J. Y., Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. Journal of Pharmaceutical Sciences 2013 103 1 29 52 10.1002/jps.23773
72. Silva J. M., Videira M., Gaspar R., Préat V., Florindo H. F., Immune system targeting by biodegradable nanoparticles for cancer vaccines. Journal of Controlled Release 2013 168 2 179 199 10.1016/j.jconrel.2013.03.010
73. Hirst S. M., Karakoti A. S., Tyler R. D., Sriranganathan N., Seal S., Reilly C. M., Anti-inflammatory properties of cerium oxide nanoparticles. Small 2009 5 24 2848 2856 2-s2.0-73849089528 10.1002/smll.200901048
74. Park J.-H., Gu L., von Maltzahn G., Ruoslahti E., Bhatia S. N., Sailor M. J., Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nature Materials 2009 8 4 331 336 2-s2.0-63049094179 10.1038/nmat2398
75. Salonen J., Laitinen L., Kaukonen A. M., Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. Journal of Controlled Release 2005 108 2-3 362 374 2-s2.0-27744566574 10.1016/j.jconrel.2005.08.017 (Pubitemid 41608668)
76. Heegaard P. M., Boas U., Sorensen N. S., Dendrimers for vaccine and immunostimulatory uses: a review. Bioconjugate Chemistry 2010 21 3 405 418 2-s2.0-77949795491 10.1021/bc900290d
77. Yang Y., Neef T., Mittelholzer C., The biodistribution of self-assembling protein nanoparticles shows they are promising vaccine platforms. Journal of Nanobiotechnology 2013 11 1 36 10.1186/1477-3155-11-36
78. Hawkins M. J., Soon-Shiong P., Desai N., Protein nanoparticles as drug carriers in clinical medicine. Advanced Drug Delivery Reviews 2008 60 8 876 885 2-s2.0-42649132499 10.1016/j.addr.2007.08.044
79. Chueh S. C., Lai M. K., Lee M. S., Chiang L. Y., Ho T. I., Chen S. C., Decrease of free radical level in organ perfusate by a novel water-soluble carbon-sixty, hexa(sulfobutyl)fullerenes. Transplantation Proceedings 1999 31 5 1976 1977 2-s2.0-0032792431 10.1016/S0041-1345(99)00234-1 (Pubitemid 29376497)
80. Magoulas G. E., Garnelis T., Athanassopoulos C. M., Synthesis and antioxidative/anti-inflammatory activity of novel fullerene-polyamine conjugates. Tetrahedron 2012 68 35 7041 7049 10.1016/j.tet.2012.06.066
81. Chen Y. W., Hwang K. C., Yen C., Lai Y., Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs. The American Journal of Physiology: Regulatory Integrative and Comparative Physiology 2004 287 1 R21 R26 2-s2.0-3042704505 10.1152/ajpregu.00310.2003 (Pubitemid 38856306)
82. Rahman M. F., Wang J., Patterson T. A., Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicology Letters 2009 187 1 15 21 2-s2.0-62149103368 10.1016/j.toxlet.2009.01. 020
83. Samberg M. E., Oldenburg S. J., Monteiro-Riviere N. A., Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environmental Health Perspectives 2010 118 3 407 413 2-s2.0-77649212361 10.1289/ehp.0901398
84. Müller K., Skepper J. N., Posfai M., Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Biomaterials 2007 28 9 1629 1642 2-s2.0-33846221563 10.1016/j.biomaterials.2006.12.003 (Pubitemid 46098969)
85. Gojova A., Guo B., Kota R. S., Rutledge J. C., Kennedy I. M., Barakat A. I., Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environmental Health Perspectives 2007 115 3 403 409 2-s2.0-34147158989 10.1289/ehp.8497 (Pubitemid 46554439)
86. Naqvi S., Samim M., Abdin M. Z., Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. International Journal of Nanomedicine 2010 5 1 983 989 2-s2.0-79954466823 10.2147/IJN.S13244
87. Blank F., Gerber P., Rothen-Rutishauser B., Biomedical nanoparticles modulate specific CD4(+) T cell stimulation by inhibition of antigen processing in dendritic cells. Nanotoxicology 2011 5 4 606 621 2-s2.0-80455144192 10.3109/17435390.2010.541293
88. Ban M., Langonné I., Huguet N., Goutet M., Effect of submicron and nano-iron oxide particles on pulmonary immunity in mice. Toxicology Letters 2012 210 3 267 275 10.1016/j.toxlet.2012.02.004
89. 2 nanoparticles. PLoS ONE 2013 8 5 e62816 10.1371/journal.pone. 0062816
90. Pagliari F., Mandoli C., Forte G., Cerium oxide nanoparticles protect cardiac progenitor cells from oxidative stress. ACS Nano 2012 6 5 3767 3775 10.1021/nn2048069
91. Falugi C., Aluigi M. G., Chiantore M. C., Toxicity of metal oxide nanoparticles in immune cells of the sea urchin. Marine Environmental Research 2012 76 114 121 2-s2.0-84858997393 10.1016/j.marenvres.2011.10.003
92. Clapp A. R., Medintz I. L., Mauro J. M., Fisher B. R., Bawendi M. G., Mattoussi H., Fluorescence resonance energy transfer between quantum dot donors and dye-labeled protein acceptors. Journal of the American Chemical Society 2004 126 1 301 310 2-s2.0-0347129672 (Pubitemid 38090370)
93. Samia A. C., Chen X., Burda C., Semiconductor quantum dots for photodynamic therapy. Journal of the American Chemical Society 2003 125 51 15736 15737 2-s2.0-0345733979 10.1021/ja0386905 (Pubitemid 37553678)
94. Lovrić J., Cho S. J., Winnik F. M., Maysinger D., Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. Chemistry & Biology 2005 12 11 1227 1234 2-s2.0-27744516368 10.1016/j.chembiol.2005.09.008 (Pubitemid 41628258)
95. Nguyen K. C., Seligy V. L., Tayabali A. F., Cadmium telluride quantum dot nanoparticle cytotoxicity and effects on model immune responses to Pseudomonas aeruginosa. Nanotoxicology 2013 7 2 202 211 10.3109/17435390.2011.648667
96. Hoshino A., Hanada S., Manabe N., Nakayama T., Yamamoto K., Immune response induced by fluorescent nanocrystal quantum dots in vitro and in vivo. IEEE Transactions on Nanobioscience 2009 8 1 51 57 2-s2.0-68149176628 10.1109/TNB.2009.2016550
97. Bruneau A., Fortier M., Gagne F., Size distribution effects of cadmium tellurium quantum dots (CdS/CdTe) immunotoxicity on aquatic organisms. Environmental Science: Processes & Impacts 2013 15 3 596 607
98. Roberts R. A., Shen T., Allen I. C., Hasan W., DeSimone J. M., Ting J. P. Y., Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles. PLoS ONE 2013 8 4 e62115 10.1371/journal.pone.0062115
99. Clichici S., Biris A. R., Catoi C., Filip A., Tabaran F., Short-term splenic impact of single-strand DNA functionalized multi-walled carbon nanotubes intraperitoneally injected in rats. Journal of Applied Toxicology 2013 34 4 332 344 10.1002/jat.2883
100. Nygaard U. C., Hansen J. S., Samuelsen M., Alberg T., Marioara C. D., Løvik M., Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. Toxicological Sciences 2009 109 1 113 123 2-s2.0-65549088539 10.1093/toxsci/kfp057
101. Laverny G., Casset A., Purohit A., Immunomodulatory properties of multi-walled carbon nanotubes in peripheral blood mononuclear cells from healthy subjects and allergic patients. Toxicology Letters 2013 217 2 91 101 10.1016/j.toxlet.2012.12.008
102. Zhi X., Fang H., Bao C., The immunotoxicity of graphene oxides and the effect of PVP-coating. Biomaterials 2013 34 21 5254 5261 10.1016/j.biomaterials. 2013.03.024
103. Tkach A. V., Yanamala N., Stanley S., Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells. Small 2013 9 9-10 1686 1690 10.1002/smll.201201546
104. Chen G.-Y., Yang H.-J., Lu C.-H., Simultaneous induction of autophagy and toll-like receptor signaling pathways by graphene oxide. Biomaterials 2012 33 27 6559 6569 10.1016/j.biomaterials.2012.05.064
105. Yue H., Wei W., Yue Z., The role of the lateral dimension of graphene oxide in the regulation of cellular responses. Biomaterials 2012 33 16 4013 4021 10.1016/j.biomaterials.2012.02.021
106. Bunz H., Plankenhorn S., Klein R., Effect of buckminsterfullerenes on cells of the innate and adaptive immune system: an in vitro study with human peripheral blood mononuclear cells. International Journal of Nanomedicine 2012 7 4571 4580 10.2147/IJN.S33773
107. Fallarini S., Paoletti T., Battaglini C. O., Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles. Nanoscale 2013 5 1 390 400 10.1039/c2nr32338a
108. Pfaller T., Puntes V., Casals E., Duschl A., Oostingh G. J., In vitro investigation of immunomodulatory effects caused by engineered inorganic nanoparticles: the impact of experimental design and cell choice. Nanotoxicology 2009 3 1 46 59 10.1080/17435390802546071
109. Yang E.-J., Choi I.-H., Immunostimulatory effects of silica nanoparticles in human monocytes. Immune Network 2013 13 3 94 101 10.4110/in.2013.13.3.94
110. Lou P. J., Cheng W., Chung Y., Cheng C., Chiu L., Young T., PMMA particle-mediated DNA vaccine for cervical cancer. Journal of Biomedical Materials Research A 2009 88 4 849 857 2-s2.0-60349128014 10.1002/jbm.a.31919
111. Kreuter J., Liehl E., Protection induced by inactivated influenza virus vaccines with polymethylmethacrylate adjuvants. Medical Microbiology and Immunology 1978 165 2 111 117 2-s2.0-0018190135 (Pubitemid 8360285)
112. Shakya A. K., Nandakumar K. S., Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases. Journal of the Royal Society Interface 2012 10 79 20120536 10.1098/rsif.2012. 0536
113. Sayin B., Somavarapu S., Li X. W., Sesardic D., Senel S., Alpar O. H., TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines. The European Journal of Pharmaceutical Sciences 2009 38 4 362 369 2-s2.0-70349998153 10.1016/j.ejps.2009.08.010
114. Petersen L. K., Ramer-Tait A. E., Broderick S. R., Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants. Biomaterials 2011 32 28 6815 6822 2-s2.0-79960558240 10.1016/j.biomaterials.2011.05.063
115. Camacho A. I., da Costa Martins R., Tamayo I., Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators. Vaccine 2011 29 41 7130 7135 2-s2.0-80052439788 10.1016/j.vaccine.2011.05.072
116. Frick S. U., Bacher N., Baier G., Functionalized polystyrene nanoparticles trigger human dendritic cell maturation resulting in enhanced CD4 + T cell activation. Macromolecular Bioscience 2012 12 12 1637 1647 10.1002/mabi.201200223
117. Córdoba E. V., Pion M., Rasines B., Glycodendrimers as new tools in the search for effective anti-HIV DC-based immunotherapies. Nanomedicine: Nanotechnology, Biology and Medicine 2013 9 7 972 984 10.1016/j.nano.2013.03.004
118. McCoy M. E., Golden H. E., Doll T. A., Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine. Malaria Journal 2013 12 1 136 10.1186/1475-2875-12-136
119. Walker S., Biophysical characterization of optimized self-assembling protein nanoparticles as a malaria vaccine [Honors Scholar Thesis] 2013 Storrs, Conn, USA University of Connecticut
120. Molino N. M., Anderson A. K. L., Nelson E. L., Szu-Wen W., Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation. ACS Nano 2013 7 11 9743 9752 10.1021/nn403085w
121. Guo Q., Dasgupta D., Doll T. A., Burkhard P., Lanar D. E., Expression, purification and refolding of a self-assembling protein nanoparticle (SAPN) malaria vaccine. Methods 2013 160 3 242 247 10.1016/j.ymeth.2013.03.025
122. Akita H., Ishii S., Miura N., A DNA microarray-based analysis of immune-stimulatory and transcriptional responses of dendritic cells to KALA-modified nanoparticles. Biomaterials 2013 34 35 8979 8990 10.1016/j.biomaterials.2013.08.003
123. Sellins K., Fradkin L., Liggitt D., Dow S., Type I interferons potently suppress gene expression following gene delivery using liposome-DNA complexes. Molecular Therapy 2005 12 3 451 459 2-s2.0-23844478428 10.1016/j.ymthe.2005.04. 008 (Pubitemid 41150130)
124. Zhou H., Mu Q., Gao N., A nano-combinatorial library strategy for the discovery of nanotubes with reduced protein-binding, cytotoxicity, and immune response. Nano Letters 2008 8 3 859 865 2-s2.0-43149095577 10.1021/nl0730155
125. Gao N., Zhang Q., Mu Q., Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NF B activation and reduces its immunotoxicity. ACS Nano 2011 5 6 4581 4591 2-s2.0-79959772416 10.1021/nn200283g
126. Jiang Y., Zhang H., Wang Y., Modulation of apoptotic pathways of macrophages by surface-functionalized multi-walled carbon nanotubes. PLoS ONE 2013 8 6 e65756 10.1371/journal.pone.0065756
127. Shahbazi M. A., Hamidi M., Mäkilä E. M., The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility. Biomaterials 2013 34 31 7776 7789 10.1016/j.biomaterials. 2013.06.052
128. Mottram P. L., Leong D., Crimeen-Irwin B., Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Molecular Pharmaceutics 2007 4 1 73 84 2-s2.0-33847232545 10.1021/mp060096p
129. Walczyk D., Bombelli F. B., Monopoli M. P., Lynch I., Dawson K. A., What the cell "sees" in bionanoscience. Journal of the American Chemical Society 2010 132 16 5761 5768 2-s2.0-77952563342 10.1021/ja910675v
130. Marano F., Hussain S., Rodrigues-Lima F., Baeza-Squiban A., Boland S., Nanoparticles: molecular targets and cell signalling. Archives of Toxicology 2011 85 7 733 741 2-s2.0-79959616151 10.1007/s00204-010-0546-4
131. Cedervall T., Lynch I., Lindman S., Understanding the nanoparticle-protein corona using methods to quntify exchange rates and affinities of proteins for nanoparticles. Proceedings of the National Academy of Sciences of the United States of America 2007 104 7 2050 2055 2-s2.0-33847789142 10.1073/pnas.0608582104 (Pubitemid 46391350)
132. Deng Z. J., Liang M., Monteiro M., Minchin R. F., Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses. Nanotoxicology 2012 7 3 314 322 10.3109/17435390.2012.655342
133. Horie M., Nishio K., Fujita K., Protein adsorption of ultrafine metal oxide and its influence on cytotoxicity toward cultured cells. Chemical Research in Toxicology 2009 22 3 543 553 2-s2.0-65949101218 10.1021/tx800289z
134. Lynch I., Dawson K. A., Protein-nanoparticle interactions. Nano Today 2008 3 1-2 40 47 2-s2.0-39749107963 10.1016/S1748-0132(08)70014-8 (Pubitemid 351298587)
135. Deng Z. J., Mortimer G., Schiller T., Musumeci A., Martin D., Minchin R. F., Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 2009 20 45 2-s2.0-70350680824 10.1088/0957-4484/20/45/455101 455101
136. Saptarshi S. R., Duschl A., Lopata A. L., Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. Journal of Nanobiotechnology 2013 11 1 1 12 10.1186/1477-3155-11-26
137. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K. A., Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proceedings of the National Academy of Sciences of the United States of America 2008 105 38 14265 14270 2-s2.0-55749091647 10.1073/pnas.0805135105
138. Sacchetti C., Motamedchaboki K., Magrini A., Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance. ACS Nano 2013 7 3 1974 1989 10.1021/nn400409h
139. Deng Z. J., Liang M., Monteiro M., Toth I., Minchin R. F., Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nature Nanotechnology 2011 6 1 39 44 2-s2.0-78650606928 10.1038/nnano.2010.250
140. Pantarotto D., Briand J., Prato M., Bianco A., Translocation of bioactive peptides across cell membranes by carbon nanotubes. Chemical Communications 2004 10 1 16 17 2-s2.0-1642540193 (Pubitemid 38121939)
141. Guo D., Zhu L., Huang Z., Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions. Biomaterials 2013 34 32 7884 7894 10.1016/j.biomaterials.2013.07.015
142. Chapple I. L. C., Reactive oxygen species and antioxidants in inflammatory diseases. Journal of Clinical Periodontology 1997 24 5 287 296 10.1111/j.1600-051X.1997.tb00760.x (Pubitemid 127731526)
143. Wiseman H., Halliwell B., Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochemical Journal 1996 313 17 29 (Pubitemid 26013419)
144. Qu G., Liu S., Zhang S., Graphene oxide induces toll-like receptor 4 (TLR4)-dependent necrosis in macrophages. ACS Nano 2013 7 7 5732 5745 10.1021/nn402330b
145. Lucas K., Maes M., Role of the toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. Molecular Neurobiology 2013 48 1 190 204 10.1007/s12035-013-8425-7
146. Ho C.-C., Luo Y.-H., Chuang T.-H., Yang C.-S., Ling Y.-C., Lin P., Quantum dots induced monocyte chemotactic protein-1 expression via MyD88-dependent Toll-like receptor signaling pathways in macrophages. Toxicology 2013 308 7 1 9 10.1016/j.tox.2013.03.003
147. Pasparakis M., Regulation of tissue homeostasis by NF-B signalling: implications for inflammatory diseases. Nature Reviews Immunology 2009 9 11 778 788 2-s2.0-70350513270 10.1038/nri2655
148. Tak P. P., Firestein G. S., NF- B: a key role in inflammatory diseases. Journal of Clinical Investigation 2001 107 1 7 11 2-s2.0-0034746919
149. Baeuerle P. A., Henkel T., Function and activation of NF- B in the immune system. Annual Review of Immunology 1994 12 141 179 2-s2.0-0028174061
150. Wang S. Z., Ma F. M., Zhao J. D., Expressions of nuclear factor-kappa B p50 and p65 and their significance in the up-regulation of intercellular cell adhesion molecule-1 mRNA in the nasal mucosa of allergic rhinitis patients. European Archives of Oto-Rhino-Laryngology 2012 270 4 1329 1334 10.1007/s00405-012-2136-y
151. Patel J. K., Clifford R. L., Deacon K., Knox A. J., Ciclesonide inhibits TNF α-and IL-1 β -induced monocyte chemotactic protein-1 (MCP-1/CCL2) secretion from human airway smooth muscle cells. The American Journal of Physiology: Lung Cellular and Molecular Physiology 2012 302 8 L785 L792 2-s2.0-84859778814 10.1152/ajplung.00257.2011
152. Sharma M., Salisbury R. L., Maurer E. I., Hussain S. M., Sulentic C. E. W., Gold nanoparticles induce transcriptional activity of NF- B in a B-lymphocyte cell line. Nanoscale 2013 5 9 3747 3756 10.1039/c3nr30071d
153. Inoue K.-I., Yanagisawa R., Koike E., Nishikawa M., Takano H., Repeated pulmonary exposure to single-walled carbon nanotubes exacerbates allergic inflammation of the airway: possible role of oxidative stress. Free Radical Biology and Medicine 2010 48 7 924 934 2-s2.0-77249172273 10.1016/j. freeradbiomed.2010.01.013
154. de Nicola M., Gattia D. M., Traversa E., Ghibelli L., Maturation and demise of human primary monocytes by carbon nanotubes. Journal of Nanoparticle Research 2013 15, article 1711 10.1007/s11051-013-1711-5